Rennova Health, Inc.
RNVA
RNVA was delisted on the 24th of October, 2017.
4 hedge funds and large institutions have $60K invested in Rennova Health, Inc. in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
20% less funds holding
Funds holding: 5 → 4 (-1)
40% less capital invested
Capital invested by funds: $100K → $60K (-$40K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$9.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$3.27K |
RNVA Hedge Fund Activity: Q4 2014 in Review
4 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Rennova Health, Inc. (RNVA) for Q4 2014, worth a combined $60K — down 40% from $100K a quarter earlier.
Fund positioning in RNVA was balanced in Q4 2014: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $9.81K. The largest seller was Citadel Advisors, cutting an estimated $3.27K.
- 4 institutional investors held Rennova Health, Inc. (RNVA) as of Q4 2014, down from 5 in Q3 2014.
- Funds reported $60K of Rennova Health, Inc. stock for Q4 2014, down 40% quarter-over-quarter.
- 0 funds opened new Rennova Health, Inc. positions in Q4 2014 and 0 closed out.
- The largest Rennova Health, Inc. buyer in Q4 2014 was Renaissance Technologies, an estimated $9.81K added.
- The largest Rennova Health, Inc. seller in Q4 2014 was Citadel Advisors, an estimated $3.27K sold.
Based on aggregated 13F filings for Q4 2014.